[go: up one dir, main page]

JPS6444856A - Anti-cancer antigen anti-serum - Google Patents

Anti-cancer antigen anti-serum

Info

Publication number
JPS6444856A
JPS6444856A JP20091687A JP20091687A JPS6444856A JP S6444856 A JPS6444856 A JP S6444856A JP 20091687 A JP20091687 A JP 20091687A JP 20091687 A JP20091687 A JP 20091687A JP S6444856 A JPS6444856 A JP S6444856A
Authority
JP
Japan
Prior art keywords
cancer antigen
cell
serum
organs
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP20091687A
Other languages
Japanese (ja)
Inventor
Toyoji Hozumi
Shuichi Matsuoka
Eikai Kiyo
Yoshiko Matsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co Ltd filed Critical Wakunaga Pharmaceutical Co Ltd
Priority to JP20091687A priority Critical patent/JPS6444856A/en
Publication of JPS6444856A publication Critical patent/JPS6444856A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PURPOSE:To obtain the anti-serum to a cancer antigen common to a plurality of organs, by producing an antibody by sensitizing a warm-blooded animal with the cancer antigen produced by the fusion of the B-lymphocyte of an animal immunized with a human cancerous cell and a tumor cell. CONSTITUTION:The B-lymphocyte (e.g., splenic cell) of an animal immunized with a human cancerous cell and a tumor cell (e.g., myeloma cell) are fused and a cancer antigen is produced by the hybridoma thereof. Said cancer antigen is not reacted with a normal cell and confirmed by an anti-human cancer monoclonal antigen specifically reacted with the cancer antigen of a plurality of organs and shows a band of a MW of 68,000-92,000 by SDS polyacrylamide gel electrophoresis and has affinity to concanavalin A lectin. This cancer antigen is injected in a mouse to produce an antibody in a living body and anti-serum is prepared. Since this anti-serum is used, the cancer antigen common to a plurality of organs can be usefully measured.
JP20091687A 1987-08-13 1987-08-13 Anti-cancer antigen anti-serum Pending JPS6444856A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20091687A JPS6444856A (en) 1987-08-13 1987-08-13 Anti-cancer antigen anti-serum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20091687A JPS6444856A (en) 1987-08-13 1987-08-13 Anti-cancer antigen anti-serum

Publications (1)

Publication Number Publication Date
JPS6444856A true JPS6444856A (en) 1989-02-17

Family

ID=16432407

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20091687A Pending JPS6444856A (en) 1987-08-13 1987-08-13 Anti-cancer antigen anti-serum

Country Status (1)

Country Link
JP (1) JPS6444856A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07331682A (en) * 1994-06-10 1995-12-19 Seibu Polymer Corp Sand penetration preventing structure at joint of underground structure
DE102016102112A1 (en) 2015-02-10 2016-08-11 Suzuki Motor Corporation INTERIOR COMPONENTS STRUCTURE

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07331682A (en) * 1994-06-10 1995-12-19 Seibu Polymer Corp Sand penetration preventing structure at joint of underground structure
DE102016102112A1 (en) 2015-02-10 2016-08-11 Suzuki Motor Corporation INTERIOR COMPONENTS STRUCTURE

Similar Documents

Publication Publication Date Title
DE3687736D1 (en) MONOCLONAL ANTIBODIES AGAINST HUMAN BREAST CANCER, CORRESPONDING HYBRIDOME, THEIR PRODUCTION AND USE.
ATE56046T1 (en) MONOCLONAL ANTIBODIES ANTI-HUMAN BREAST CARCINOMA CELLS AND THEIR USE IN DIAGNOSIS AND THERAPY.
NL300069I2 (en) Monoclonal and chimeric antibodies that are specific to human.
KR880700061A (en) Monoclonal antibodies against antigens related to human cancer tumors
DK180380A (en) HYBRID CELL LINE AND PROCEDURES FOR PRODUCING AND USING THEREOF
NZ222309A (en) Antibodies (including chimeric antibodies) to a human tumour antigen, polynucleotides encoding them, detection of the antigen by immunoassay and imaging methods and also cell killing methods
DK517380A (en) HYBRID CELL LINE AND PROCEDURES FOR PRODUCING AND USING THEREOF
ATE70309T1 (en) HUMAN MONOCLONAL ANTIBODIES AGAINST BACTERIAL TOXINS.
FI101937B1 (en) A method for producing a monoclonal antibody that reacts with human cachectin
DE3854194D1 (en) MONOCLONAL ANTIBODIES AGAINST GLYCOSYLATED ALBUMIN, HYBRID CELL LINES THAT PRODUCE THESE ANTIBODIES AND THEIR USE.
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
DK517280A (en) HYBRID CELL LINE AND PROCEDURES FOR PRODUCING AND USING THEREOF
DK517180A (en) HYBRID CELL LINE AND PROCEDURES FOR PRODUCING AND USING THEREOF
JPS6444856A (en) Anti-cancer antigen anti-serum
NO861577L (en) ANTIGEN, ANTIBODY AND PROCEDURE FOR ITS MANUFACTURING AND USE THEREOF FOR DIAGNOSIS.
EP0119859A3 (en) Monoclonal antibodies, processes for their preparation and methods for their use
DE3784364D1 (en) TUMOR ASSOCIATED ANTIG.
EP0243058A3 (en) A novel tumor associated antigen
JPS6445397A (en) Cancer antigen
SE8401946D0 (en) ANTIBODY TO HUMAN PROSTATE CANCER